SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurocrine Biosciences (NBIX) -- Ignore unavailable to you. Want to Upgrade?


To: NeuroInvestment who wrote (121)3/14/1999 9:24:00 PM
From: LLCF  Read Replies (1) | Respond to of 1834
 
NBIX research report mentioned in Barron's this weekend. Gruntal rates the stock a "Strong Buy" partially based on the $78mill collaborative agreement with America Home Products. Then goes on to say that "total deals executed by the company, including the new one, provide research and development finds of nearly $330 million, or more that $18 a share. The new American Home agreement alone adds $4.30 a share."